(a) Taylor diagrams of Khandelwal et al. [13], Brabdas et al, Kumar et al. [12] models. (b) Taylor diagrams of Ranjbar-Karami et al. [14], Christaras et al. [52], Feng et al. [16],... by Fahd Saeed Alakbari (10701871)

Subjects:

(a, b). The statistical error analyses for the models using the same dataset. by Fahd Saeed Alakbari (10701871)

Subjects:

The comparison of ν_s – RHOB trends models with experimental measurements. by Fahd Saeed Alakbari (10701871)

Subjects:

The comparison of ν_s – DTs trends models with experimental measured values for RHOB = 2.33 g/cc and DTc = 118.67 us/ft. by Fahd Saeed Alakbari (10701871)

Subjects:

The optimized GPR approach’s cross-plotting for the training dataset. by Fahd Saeed Alakbari (10701871)

Subjects:

Methodology flowchart. by Fahd Saeed Alakbari (10701871)

Subjects:

The most common machine learning methods to predict ν_s. by Fahd Saeed Alakbari (10701871)

Subjects:

Trend analysis of the ν_s – DTc in the range found in the dataset used for the optimized GPR. by Fahd Saeed Alakbari (10701871)

Subjects:

Statistical error analyses of the proposed or optimized GPR model. by Fahd Saeed Alakbari (10701871)

Subjects:

Fracture pressure based on proposed GPR Poisson’s ratio model. by Fahd Saeed Alakbari (10701871)

Subjects:

Comparison of ν_s measured and predicted estimates of the optimized GPR approach for (a) training, (b) validation, and (c) testing datasets. by Fahd Saeed Alakbari (10701871)

Subjects:

Effects of GCN2 inhibitor GCN2iB on larval mortality of Cry1Ac-treated <i>H. armigera.</i> by Caihong Zhang (1633294)

LPS induces ferroptosis of lung epithelial cells. by Yaping Yuan (2734228)

Subjects:

Effect of DM, and/or <i>M. charantia</i> on the (I) glucose; (II) HOMA IR, (III) QUICKI levels; (IV) GLUT4; (V) AMPK; (VI) insulin; (VII) leptin levels in the control and different... by Amoura M. Abou-El-Naga (21001524)

Original uncropped Western blot images. by Yaping Yuan (2734228)

Subjects:

Data. by Michael C. Payne (2664379)

Subjects:

Prevalence of <i>Wb</i> microfilaremia and circulating filarial antigenemia before and after MDA in annual and semiannual intervention areas. by Michael C. Payne (2664379)

Subjects:

Changes in Mf (A and B) CFA (C and D) prevalence at baseline, 1, 2 and 3 years after starting MDA. by Michael C. Payne (2664379)

Subjects:

Sentinel sites located within areas treated with MDA semiannually (solid red line) or annually (dashed blue line). by Michael C. Payne (2664379)

Subjects:

Directly observed antifilarial drug ingestion rates in semiannual and annual mass drug administration (MDA) areas. by Michael C. Payne (2664379)

Subjects: